Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial
- PMID: 17902730
- DOI: 10.2165/00128071-200708050-00003
Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial
Abstract
Background: 5% topical minoxidil solution has been widely used to stimulate new hair growth and help stop hair loss in men with androgenetic alopecia (AGA). However, it is not convenient for patients to continue applying the solution twice daily on a regular basis. Tretinoin is known to increase the percutaneous absorption of minoxidil and, therefore, to enhance the response of AGA to minoxidil. For this reason, it was assumed that tretinoin would be helpful in alleviating the inconvenience associated with the recommended twice-daily application of minoxidil.
Objective: To compare the efficacy and safety of therapy using a combined solution of 5% minoxidil and 0.01% tretinoin once daily with those of the conventional 5% topical minoxidil therapy applied twice daily in the treatment of AGA.
Methods: A total of 31 male patients (aged 28-45 years, mean 39.7+/-4.5) with AGA (Hamilton-Norwood classification type III-V) were randomly assigned into two groups, one in which 5% minoxidil was applied to the scalp twice daily and the other in which the combined agent was applied once daily at night together with a vehicle placebo in the morning. The efficacy parameters were: (i) changes in total hair count, non-vellus hair count, anagen hair ratio, linear hair growth rate, and mean hair diameter assessed by macrophotographic image analysis; and (ii) the patient's and investigator's subjective assessments.
Results: After therapy, increases in the macrophotographic variables of total hair count and non-vellus hair count were shown in both treatment groups. There were no statistically significant differences between the two treatment groups with respect to changes in macrophotographic variables or scores on subjective global assessments by patients and the investigator. The incidence of adverse effects such as pruritus or local irritation was similar in the 5% minoxidil group (4 of 14 subjects) and the combined agent group (5 of 15 subjects).
Conclusion: The efficacy and safety of combined 5% minoxidil and 0.01% tretinoin once-daily therapy appear to be equivalent to those of conventional 5% minoxidil twice-daily therapy for the treatment of AGA.
Similar articles
-
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.J Am Acad Dermatol. 2004 Apr;50(4):541-53. doi: 10.1016/j.jaad.2003.06.014. J Am Acad Dermatol. 2004. PMID: 15034503 Clinical Trial.
-
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.J Am Acad Dermatol. 2002 Sep;47(3):377-85. doi: 10.1067/mjd.2002.124088. J Am Acad Dermatol. 2002. PMID: 12196747 Clinical Trial.
-
Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.J Cosmet Dermatol. 2019 Feb;18(1):215-220. doi: 10.1111/jocd.12541. Epub 2018 Apr 16. J Cosmet Dermatol. 2019. PMID: 29659116 Clinical Trial.
-
Androgenetic alopecia: an evidence-based treatment update.Am J Clin Dermatol. 2014 Jul;15(3):217-30. doi: 10.1007/s40257-014-0077-5. Am J Clin Dermatol. 2014. PMID: 24848508 Review.
-
The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.G Ital Dermatol Venereol. 2018 Feb;153(1):102-106. doi: 10.23736/S0392-0488.17.05781-9. G Ital Dermatol Venereol. 2018. PMID: 29319278 Review.
Cited by
-
Combination and Rotational Therapy in Androgenetic Alopecia.J Cutan Aesthet Surg. 2023 Apr-Jun;16(2):71-80. doi: 10.4103/JCAS.JCAS_212_22. J Cutan Aesthet Surg. 2023. PMID: 37554681 Free PMC article.
-
Duo-role Platelet-rich Plasma: temperature-induced fibrin gel and growth factors' reservoir for microneedles to promote hair regrowth.J Adv Res. 2024 Jan;55:89-102. doi: 10.1016/j.jare.2023.02.014. Epub 2023 Feb 26. J Adv Res. 2024. PMID: 36849045 Free PMC article.
-
Direct Reprograming of Mouse Fibroblasts into Dermal Papilla Cells via Small Molecules.Int J Mol Sci. 2022 Apr 11;23(8):4213. doi: 10.3390/ijms23084213. Int J Mol Sci. 2022. PMID: 35457029 Free PMC article.
-
Minoxidil, Platelet-Rich Plasma (PRP), or Combined Minoxidil and PRP for Androgenetic Alopecia in Men: A Cost-Effectiveness Markov Decision Analysis of Prospective Studies.Cureus. 2021 Dec 30;13(12):e20839. doi: 10.7759/cureus.20839. eCollection 2021 Dec. Cureus. 2021. PMID: 35141088 Free PMC article.
-
Beneficial effects of pumpkin seed oil as a topical hair growth promoting agent in a mice model.Avicenna J Phytomed. 2019 Nov-Dec;9(6):499-504. doi: 10.22038/AJP.2019.13463. Avicenna J Phytomed. 2019. PMID: 31763209 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous